Paramount is set to win the rights to broadcast the majority of Champions League games in the United Kingdom and the Republic of Ireland.

Sources briefed on the bidding process indicate the streaming giant – which already holds the rights to screen Europe’s premier men’s club competition in the United States – is the preferred option for the next broadcasting cycle, from 2027 to 2031, wiht an official announcement to follow.

The American firm’s expected win, at the expense of current UK rights-holder TNT Sports, follows a new-look tender process designed to attract a global streaming platform to the negotiating table.

Paramount is also set to win the rights for the majority of games in Germany, with Amazon Prime Video keeping hold of the first-pick Champions League games on Tuesdays in the UK and Ireland. In Germany and Italy, that first-pick game is highly likely to switch to Wednesdays.

Paramount declined to comment when approached.

UC3, the joint venture between UEFA and european Football Clubs, the new name for the European Club Association, announced the start of the tender process in Europe’s five biggest markets – France, Germany, Italy, spain and the United Kingdom and Ireland – on October 13.

It is indeed the first rights cycle run by American agency Relevent, which replaced UEFA’s long-term global sales partner TEAM Marketing in 2024, with the European governing body and the top clubs looking to surpass the €5billion (£4.3bn; $5.8bn) mark in terms of annual media income from the continent’s club competitions.

This story will be updated

The Rise of Synthetic Biology

Synthetic biology, a rapidly evolving field, applies engineering principles to biology. It aims to design and construct new biological parts, devices, and systems, or to redesign existing natural biological systems for useful purposes. Unlike genetic engineering, which typically modifies existing organisms, synthetic biology focuses on creating entirely new biological functions.

Core Concepts and Approaches

at its heart, synthetic biology relies on several key concepts. Standardization of biological parts – like genes, promoters, and ribosomes – allows for predictable assembly and function. This is frequently enough achieved through the use of BioBricks,standardized,modular DNA sequences. Modularity enables the creation of complex systems from simpler, interchangeable components. abstraction simplifies the design process by hiding unnecessary details, allowing engineers to focus on the overall system behaviour.

Researchers employ a variety of techniques, including DNA synthesis, metabolic engineering, and genome editing (like CRISPR-Cas9) to build and test their designs. Computational modeling plays a crucial role in predicting system behavior before physical construction, accelerating the design-build-test-learn cycle.

Applications Across Industries

The potential applications of synthetic biology are vast and span numerous industries:

• Medicine: Developing novel diagnostics, therapeutics (including personalized medicine), and drug delivery systems. For example, engineered bacteria can be designed to detect and destroy cancer cells. National Cancer Institute
• Biomanufacturing: Producing enduring chemicals,materials,and fuels. Synthetic biology offers a pathway to replace petroleum-based processes with environmentally kind alternatives. U.S.Department of energy
• Agriculture: Creating crops with enhanced yields, pest resistance, and nutritional value. Engineering nitrogen fixation in non-leguminous plants could reduce the need for synthetic fertilizers.
• Environmental Remediation: Designing microorganisms to clean up pollutants and toxins. Synthetic biology can address challenges like plastic degradation and oil spill cleanup.

Challenges and Ethical Considerations

Despite its promise, synthetic biology faces significant challenges.Biosecurity concerns arise from the potential for misuse of the technology to create harmful pathogens. Biosafety requires careful consideration of the environmental impact of releasing engineered organisms. Intellectual property issues surrounding the ownership of synthetic biological designs are complex.

Ethical debates center on the potential for unintended consequences, the responsible innovation of powerful technologies, and the equitable access to benefits derived from synthetic biology. Ongoing dialog and robust regulatory frameworks are essential to navigate these challenges.

Future Outlook

The field of synthetic biology is poised for continued growth. advances in DNA synthesis, automation, and computational tools will accelerate the pace of innovation. The convergence of synthetic biology with other fields, such as artificial intelligence and nanotechnology, will unlock new possibilities. As our understanding of biological systems deepens, synthetic biology will play an increasingly crucial role in addressing global challenges in health, sustainability, and beyond.